CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
Ha-Neui Kim, Jong-Ho Lee, Won Jong Jin, Zang Hee Lee
jbm. 2012;19(2):111-120.   Published online November 16, 2012
DOI: https://doi.org/10.11005/jbm.2012.19.2.111

Excel Download

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
Journal of Bone Metabolism. 2012;19(2):111   Crossref logo
Link1 Link2 Link3

α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κB Ligand Expression of Osteoblasts
Journal of Bone Metabolism. 2018;25(1):23   Crossref logo
Link1 Link2 Link3

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
Journal of Bone Metabolism. 2012;19(2):121   Crossref logo
Link1 Link2 Link3

Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways
Journal of Bone Metabolism. 2017;24(4):207   Crossref logo
Link1 Link2 Link3

Osteoprotegerin (OPG) und Receptor Activator for Nuclear Factor kappaB Ligand (RANKL) als Risikofaktoren für Entstehung und Schweregrad einer Koronaren Herzerkrankung – ein Review
Wiener Medizinische Wochenschrift. 2011;161(23-24):565-570   Crossref logo
Link1 Link2 Link3 Link4

Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas
Journal of Oral Pathology and Medicine. 2004;33(1):46-52   Crossref logo
Link1 Link2

Crocin inhibits RANKL-induced osteoclast formation and bone resorption by suppressing NF-κB signaling pathway activation
Immunobiology. 2017;222(4):597-603   Crossref logo
Link1 Link2

Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
Molecules. 2021;26(7):1886   Crossref logo
Link1

Osteoprotegerin (OPG) and receptor activator of nuclear factor kappab ligand (RANKL) in pediatric chronic kidney disease (CKD)
Bone. 2009;45:S65   Crossref logo
Link1 Link2

Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-κB ligand (RANKL) in osteoclast cells
Bone. 2005;36(5):832-839   Crossref logo
Link1 Link2